Gelonghui August 28th 丨Jinshi Ya Pharmaceutical (300434.SZ) announced its 2023 semi-annual report. Operating income for the reporting period was 634 million yuan, up 32.18% year on year; net profit attributable to shareholders of listed companies was 156 million yuan, up 89.45% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,496 billion yuan, up 137.42% year on year; basic earnings per share were 0.3876 yuan.
金石亚药(300434.SZ)：上半年净利增89.45%至1.56亿元
Jinshi Yayao (300434.SZ): Net profit increased 89.45% to 156 million yuan in the first half of the year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney